Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ALGT | ASTH |
|---|---|---|
| Price | $75.14 | $36.81 |
| Change today | ▼ 3.18% | ▲ 2.59% |
| Market cap | $2.05B | $2.05B |
| Return, 3 months | -32.4% | -21.7% |
| Return, year to date | -11.9% | +48.4% |
| Return, 1 year | +17.6% | +27.5% |
| P/E (TTM) | 64.8 | 44.9 |
| P/B | 1.2 | 2.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +3.7% | – |
| Net profit growth (YoY) | +81.4% | – |
| Gross margin | 15.4% | – |
| Operating margin | 6.7% | – |
| Net margin | -1.7% | – |
| Return on equity | – | – |
| Analyst target vs. price | +68.9% | +41.3% |
| Analyst buy share | 73% | 89% |
| RSI (14) | 41 | 51 |
| 30-day volatility | 38.4% | 45.7% |
| Max drawdown, 1 year | -39.2% | -46.4% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
